구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Diphenhydramine (Diphenhydramine) Janssen Research & Development, LL…·Lymphoma, Non-Hodgkin 132 trials |
|---|---|
Overview Program | Diphenhydramine |
Overview Company | Janssen Research & Development, LLC |
Overview Modality | ANTIBODY |
Overview Target | Lymphoma, Non-Hodgkin |
Overview Indication | Pompe Disease |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
Overview Content status | Limited Data |
Overview Data Confidence | Data Confidence · Low |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
MoA Mechanism | and preclinical assessment tools |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | PD |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Comparative Efficacy of Interventions for the Prevention and Treatment of Postpartum Depression: A Bayesian Network Meta-analysis.. Postpartum depression (PPD) is a highly prevalent but under-reported and undertreated disorder that affects mothers and infants alike. The management of PPD has to be thoughtfully catered to limit the exposure of infants to harmful drugs. This network meta-analysis (N… |
Clinical Safety signal | Comparative Efficacy of Interventions for the Prevention and Treatment of Postpartum Depression: A Bayesian Network Meta-analysis.. Postpartum depression (PPD) is a highly prevalent but under-reported and undertreated disorder that affects mothers and infants alike. The management of PPD has to be thoughtfully catered to limit the exposure of infants to harmful drugs. This network meta-analysis (N… |
Clinical Selected reported efficacy | ORR 70.5% |
Clinical Reported ORR | 70.5% |
Clinical Result source | ClinicalTrials.gov NCT05405166 |
Clinical Program phase | PHASE_2 |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT05405166 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | Diphenhydramine (Diphenhydramine) Janssen Research & Development, LL…·Lymphoma, Non-Hodgkin 132 trials |
|---|---|
Overview Program | Diphenhydramine |
Overview Company | Janssen Research & Development, LLC |
Overview Modality | ANTIBODY |
Overview Target | Lymphoma, Non-Hodgkin |
Overview Indication | Pompe Disease |
Overview Phase | PHASE_2 |
Overview Status | RECRUITING |
Overview Content status | Limited Data |
Overview Data Confidence | Data Confidence · Low |
Overview Development Signal | Development Signal · Emerging |
Overview Approval status | Investigational |
MoA Mechanism | and preclinical assessment tools |
PK/PD Species | Rat |
PK/PD Animal (cat.) | Rat |
PK/PD Experiment | PD |
Toxicology Species | Rat |
Toxicology Animal (cat.) | Rat |
Toxicology Major finding | Comparative Efficacy of Interventions for the Prevention and Treatment of Postpartum Depression: A Bayesian Network Meta-analysis.. Postpartum depression (PPD) is a highly prevalent but under-reported and undertreated disorder that affects mothers and infants alike. The management of PPD has to be thoughtfully catered to limit the exposure of infants to harmful drugs. This network meta-analysis (N… |
Clinical Safety signal | Comparative Efficacy of Interventions for the Prevention and Treatment of Postpartum Depression: A Bayesian Network Meta-analysis.. Postpartum depression (PPD) is a highly prevalent but under-reported and undertreated disorder that affects mothers and infants alike. The management of PPD has to be thoughtfully catered to limit the exposure of infants to harmful drugs. This network meta-analysis (N… |
Clinical Selected reported efficacy | ORR 70.5% |
Clinical Reported ORR | 70.5% |
Clinical Result source | ClinicalTrials.gov NCT05405166 |
Clinical Program phase | PHASE_2 |
Clinical Trial activity | No active/completed counts |
Clinical Trial ref | NCT05405166 |
추천 비교
추천 비교